Connect with us

Health

Global Benign Prostatic Hyperplasia Market will Grow Well in 2019

mm

Published

on

According to the research carried out by Market Research Hub (MRH), it has been stated that global benign prostatic hyperplasia market is expected to witness good growth in the coming time. The research highlighted the impact of a variety of factors such as drivers, opportunities and restraints which influence the market size and status in 2019 as well as in the years to come. In the study, the present and the future market situations extending till 2025 have been mentioned clearly. It also provides a detailed analysis of the competitive landscape and the role of prime market players in the sector.

Benign prostatic hyperplasia occurs in the aging men due to the multiplication of prostatic cells. This leads to problems such as infections in the urinary tract and urinary retention. The research indicated that most of the people suffering from prostatic hypertrophy fall into old age group, which is driving the market on a large scale. Since 2018, the size of the market has grown well and the majority of the growth has fallen in the regions of the United States, Europe, and China.

Out of all the geographical regions mentioned in the report, North America offers the best infrastructure for prostatic hyperplasia treatment. It is due to the fact that North America offers excellent healthcare infrastructure, high expenditure on urological disorders and also spread awareness about BPH cure on a large scale. The size of the BPH market will continue to grow until 2025. The market is segmented by product types such as drug therapy and dialysis etc. And, also it is segmented on the basis of application in hospitals and Clinics.

Michelle has been a part of the journey ever since Bigtime Daily started. As a strong learner and passionate writer, she contributes her editing skills for the news agency. She also jots down intellectual pieces from categories such as science and health.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

40 and Pregnant: How IVF has Helped Women have Children Later in Life

mm

Published

on

As the reports of a 62-year-old Spanish woman giving birth after IVF treatment, or Daljinder Kaur giving birth at the age of 72 emerged earlier this year, women all around the world have been given a new ray of hope at becoming mothers even at a later age in life.

There isn’t a doubt that assisted reproductive techniques has been able to help women across different age brackets who face infertility or any other social conditions restricting them from being mothers.

IVF has been a boon in helping couples provide infertility solutions, helping them reproduce. However, the success of a couple at pregnancy calls for the inputs of a healthcare scientist, an embryologist in particular, who plays an imperative role in the entire process.  

Providing diagnostic services and embryological procedures, a reproductive embryologist performs careful examination of quality embryos to help couples have the best chance at becoming parents.

Embryo quality is one of the most important factors based on which a women’s pregnancy is defined. Embryo quality correlates with the maternal age, causes of infertility, ovarian stimulation parameters or embryo cohort size, and the outcome of the IVF cycle invariably depends on the above factors.

“As every woman is different, so the quality, gene expression and development of the embryo vary. However, as you age, the embryo quality is bound to deteriorate which increases the chances of infertility of aneuploidy, stating the abnormality of the embryos,” stated Dr. Goral Gandhi, an embryologist who is also a community advocate and educator of IVF and ART in India.

So how can older mothers, who want to opt for IVF or maybe conceive on their own make sure that their embryos are as healthy as possible? The answer lies in embryo testing, as it helps mitigate the chances of an unhealthy pregnancy, ensuring that the fetus is devoid of chromosomal abnormalities before implantation, suggests Dr Goral Gandhi. Her work in research and evaluation of pre-implantation genetic screening technology, and fertility-treatment-assisted pregnancies makes Gandhi an established authority.

“Older women understand their time is limited. If they lose three months because of a miscarriage, that’s a lot of time. Most patients like the idea of having as much information in front of them as possible, so they don’t have to go through the very difficult waiting period between the embryo transfer and the pregnancy test if the embryo wouldn’t have resulted in pregnancy,” says Goldman, an assistant professor of obstetrics and gynecology in reproductive endocrinology and infertility at Northwestern University Feinberg School of Medicine.

When it comes to women above 30, it is deemed appropriate to transfer multiple embryos, to boost the overall success of the procedure. The choice is, however, elective and can be best if decided upon the consideration of the embryologist. “Numbers for live birth rates show that older DNA can be rescued by modern IVF, and this offers great hope to women in their 40s who hope to be a mum,” Queensland Fertility Group medical director Dr David Molloy told The Sunday Mail.

Although ART has been used to treat infertility in both men, women of all age brackets, it calls for an extensive evaluation of treatment options by both the patient and the doctor before opting for any procedure.

Your age shouldn’t be a bar to measure your success and ability as a parent, and IVF has helped women exceed their fertility limits, and give birth to healthy babies regardless of their age.

Continue Reading

Trending